FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Fate Therapeutics's Free Cash Flow for the
three
months ended in Dec. 2023 was $-36.82 Mil. Fate Therapeutics's Revenue for the
three
months ended in Dec. 2023 was $1.68 Mil. Therefore, Fate Therapeutics's FCF Margin % for the quarter that ended in Dec. 2023 was -2,196.78%.
As of today, Fate Therapeutics's current FCF Yield % is -22.06%.
The historical rank and industry rank for Fate Therapeutics's FCF Margin % or its related term are showing as below:
FATE'
s FCF Margin % Range Over the Past 10 Years
Min: -938.68 Med: -687.87 Max: -140.49
Current: -217.86
During the past 13 years, the highest FCF Margin % of Fate Therapeutics was -140.49%. The lowest was -938.68%. And the median was -687.87%.
FATE's FCF Margin % is ranked worse than 55.44% of 1030
companies
in the Biotechnology industry
Industry Median: -149.715
vs FATE: -217.86
Fate Therapeutics FCF Margin % Historical Data
The historical data trend for Fate Therapeutics's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Fate Therapeutics Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
FCF Margin %
-848.03
-140.49
-382.43
-294.68
-217.86
Fate Therapeutics Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
FCF Margin %
-185.02
-54.37
-3,289.60
-1,997.84
-2,196.78
Competitive Comparison
For the Biotechnology subindustry, Fate Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fate Therapeutics FCF Margin % Distribution
For the Biotechnology industry and Healthcare sector, Fate Therapeutics's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Fate Therapeutics's FCF Margin % falls into.
Fate Therapeutics FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Fate Therapeutics's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fate Therapeutics FCF Margin % Related Terms
Thank you for viewing the detailed overview of Fate Therapeutics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Fate Therapeutics (Fate Therapeutics) Business Description
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and immune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FATE has been successfully added to your 